RE:RE:RE:RE:RE:RE:RE:RE:RE:Price action "No ifs and buts Proph."
If there are no ifs and buts in life give us a list of 15 stocks that are all up big in the next week. I want no ifs and buts from you. You know the future without ifs or buts is your claim. The truth is that the beta glucan pill was a compelling opportunity. The trial only cost maybe $1.5 million yet the upside could have been hundreds-of-millions. The risk/reward was compelling. The scientific literaure supports a trial. Oat beta glucan cholesterol lowering health claims are a fact. Would a pharma-grade pill at varying doses needed to be tested. Gilles got the pill developed as no one else in history and the trial was completed. The pursuit of the pill led to PGX. CZO can go back to PGX-OBG in the future for a drink. CZO also leaned some other data from the pill trial that could support another opportunity. Given the strength of CZO's pipeline, however, it has other immediate opportunities that are more compelling.